trending Market Intelligence /marketintelligence/en/news-insights/trending/oeugelaf4_1srv8vac3qqg2 content esgSubNav
In This List

AIT Therapeutics to change fiscal year-end to March 31

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


AIT Therapeutics to change fiscal year-end to March 31

AIT Therapeutics, Inc.'s board has approved to change the company's fiscal year-end to March 31 from Dec. 31.

The change becomes effective as of March 31, the New York-based medical device maker said in an SEC filing.

AIT plans to file a Form 10-KT covering the three-month transition period from Jan. 1 to March 31 on or before Aug. 8, it said in the filing.